These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21944050)

  • 1. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer].
    Zhou YJ; Wan FL; Yao LH; Feng LY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
    Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
    Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E and survival in patients with breast cancer.
    Keyomarsi K; Tucker SL; Buchholz TA; Callister M; Ding Y; Hortobagyi GN; Bedrosian I; Knickerbocker C; Toyofuku W; Lowe M; Herliczek TW; Bacus SS
    N Engl J Med; 2002 Nov; 347(20):1566-75. PubMed ID: 12432043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis.
    Yoshida T; Kinugasa T; Akagi Y; Kawahara A; Romeo K; Shiratsuchi I; Ryu Y; Gotanda Y; Shirouzu K
    Anticancer Res; 2011 Jul; 31(7):2517-25. PubMed ID: 21873169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
    Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
    Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival.
    Milne AN; Carvalho R; Jansen M; Kranenbarg EK; van de Velde CJ; Morsink FM; Musler AR; Weterman MA; Offerhaus GJ
    J Clin Pathol; 2008 Mar; 61(3):311-6. PubMed ID: 18305181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.